Pro

Rita Marker, JD, Executive Director, and Kathi Hamlon, Policy Analyst, both of the of the International Task Force on Euthanasia and Assisted Suicide, wrote in a Jan. 2010 article titled "Euthanasia and Assisted Suicide: Frequently Asked Questions" on InternationalTaskForce.org:

“Perhaps one of the most important developments in recent years is the increasing emphasis placed on health care providers to contain costs. In such a climate, euthanasia or assisted suicide certainly could become a means of cost containment…

Savings to governments could become a consideration. Drugs for assisted suicide cost about $75 to $100, making them far less expensive than providing medical care. This could fill the void from cutbacks for treatment and care with the ‘treatment’ of death…

Legalized euthanasia or assisted suicide raises the potential for a profoundly dangerous situation in which the ‘choice’ of assisted suicide or euthanasia is the only affordable option for some people.”

Jan. 2010